Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
Zur Rose, the Swiss online pharmacy that went public last year, plans to raise Sfr200m via a rights issue to fund its takeover of the e-commerce operations of Medpex, a competitor in Germany. -
Indonesian paper manufacturer Fajar Surya Wisesa started gauging interest on Thursday for a primary capital increase worth as much as Rph3.9tr ($260m) at its market price.
-
South Korea’s Lotte Tour Development has raked in W215.8bn ($191.3m) after wrapping an oversubscribed rights issue.
-
The impasse at Bandhan Bank looks set to be resolved after the Indian markets regulator waived its lock-up requirement for newly-listed firms, allowing the lender to comply with central bank demands for it to sell shares.
-
Azure Power Global, the Indian solar energy producer, raised $185m from a follow-on offering after its Canadian shareholder stepped in to buy more shares than expected.
-
Singapore-listed Hong Leong Asia plans to raise S$202.3m ($146.3m) from a rights offering to help pay for a land acquisition in the city-state.
